GPT (ALT)

The Cypress Diagnostics kit GPT (ALT) is an in vitro diagnostic medical device intended to be used for the quantitative measurement of GPT (ALT) in human serum or plasma. The device is not automated. The measurement of GPT (ALT) is intended to be used for the screening for liver disorders, the aid in diagnosis of liver disease and the monitoring of the effectiveness of liver disease treatment. This kit is intended to be used by healthcare professionals in a laboratory-based testing environment.

2 - 8 °C

The enzyme alanine aminotransferase (ALT) or glutamate pyruvate transaminase (GPT) is widely reported in a variety of tissue sources. The major source of ALT is of hepatic origin and has led to the application of ALT determinations to the study of hepatic diseases. Elevated serum levels are found in hepatitis, cirrhosis and obstructive jaundice. When ALT is determined together with GOT (AST), in case of myocardial infarcts, the ALT levels will stay within the normal limits or only be slightly elevated in comparison to highly elevated AST levels.